Therapeutic N-heterocyclic carbenes : an interview with Alejandro Bugarin
Dr Bugarin is currently an Associate Professor of Chemistry and Physics at Florida Gulf Coast University. He has published more than 50 peer-reviewed publications (h-index = 18). His research group is developing new methodology to improve or reveal novel reactivity of triazenes, N-Heterocyclic carbenes, heterobimetallic catalysts, and other versatile molecules. In addition, he recently joined research efforts to build on the isolation, characterization, and biological evaluation of natural products.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 14(2022), 13 vom: 17. Juli, Seite 941-942 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bugarin, Alejandro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2465-56-7 |
|---|
| Anmerkungen: |
Date Completed 21.06.2022 Date Revised 18.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2022-0090 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341340995 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341340995 | ||
| 003 | DE-627 | ||
| 005 | 20240319232035.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2022-0090 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1336.xml |
| 035 | |a (DE-627)NLM341340995 | ||
| 035 | |a (NLM)35611681 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bugarin, Alejandro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Therapeutic N-heterocyclic carbenes |b an interview with Alejandro Bugarin |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.06.2022 | ||
| 500 | |a Date Revised 18.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Dr Bugarin is currently an Associate Professor of Chemistry and Physics at Florida Gulf Coast University. He has published more than 50 peer-reviewed publications (h-index = 18). His research group is developing new methodology to improve or reveal novel reactivity of triazenes, N-Heterocyclic carbenes, heterobimetallic catalysts, and other versatile molecules. In addition, he recently joined research efforts to build on the isolation, characterization, and biological evaluation of natural products | ||
| 650 | 4 | |a Interview | |
| 650 | 4 | |a N-heterocyclic carbene | |
| 650 | 4 | |a anticancer drug | |
| 650 | 4 | |a antimicrobial drug | |
| 650 | 4 | |a gold | |
| 650 | 4 | |a interview | |
| 650 | 4 | |a palladium | |
| 650 | 4 | |a silver | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Biological Products |2 NLM | |
| 650 | 7 | |a carbene |2 NLM | |
| 650 | 7 | |a 2465-56-7 |2 NLM | |
| 650 | 7 | |a Methane |2 NLM | |
| 650 | 7 | |a OP0UW79H66 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 14(2022), 13 vom: 17. Juli, Seite 941-942 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:13 |g day:17 |g month:07 |g pages:941-942 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2022-0090 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2022 |e 13 |b 17 |c 07 |h 941-942 | ||